Production (Stage)
HCA Healthcare, Inc.
HCA
$376.59
-$0.05-0.01%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.61B | 1.44B | 1.27B | 1.46B | 1.59B |
| Total Depreciation and Amortization | 860.00M | 856.00M | 842.00M | 819.00M | 795.00M |
| Total Amortization of Deferred Charges | 11.00M | 9.00M | 9.00M | 8.00M | 9.00M |
| Total Other Non-Cash Items | 857.00M | 678.00M | 266.00M | -35.00M | 604.00M |
| Change in Net Operating Assets | -1.69B | -422.00M | 1.13B | -282.00M | -530.00M |
| Cash from Operations | 1.65B | 2.56B | 3.52B | 1.97B | 2.47B |
| Capital Expenditure | -991.00M | -1.29B | -1.19B | -1.28B | -1.12B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -227.00M | -42.00M | -93.00M | -35.00M | -96.00M |
| Divestitures | 161.00M | 16.00M | 1.00M | 1.00M | 310.00M |
| Other Investing Activities | 25.00M | -35.00M | -69.00M | -17.00M | 1.00M |
| Cash from Investing | -1.03B | -1.35B | -1.35B | -1.33B | -903.00M |
| Total Debt Issued | 5.45B | 0.00 | 3.01B | 0.00 | 4.48B |
| Total Debt Repaid | -3.90B | -64.00M | -927.00M | 647.00M | -3.95B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.51B | -1.70B | -1.80B | -1.37B | -1.18B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -180.00M | -165.00M | -169.00M | -171.00M | -185.00M |
| Other Financing Activities | -367.00M | -234.00M | -231.00M | -202.00M | -388.00M |
| Cash from Financing | -1.50B | -2.16B | -110.00M | -1.09B | -1.22B |
| Foreign Exchange rate Adjustments | 3.00M | -5.00M | 4.00M | 1.00M | -1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -873.00M | -955.00M | 2.06B | -453.00M | 349.00M |